ArticleAnnals of surgical oncology2024

Can Immune Checkpoint Inhibitors Pave the New Way for "Conversion Surgery" in Unresectable Esophageal Cancer?

Sho Sato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.